Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$7.10
+0.85%
Mkt Cap $528.74M
Mkt Cap
$528.74M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.47
NASDAQ·Healthcare·Biotechnology
$7.10
+0.85%
Mkt Cap $528.74M
Mkt Cap
$528.74M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.47